<?xml version="1.0" encoding="UTF-8"?>
<p>The pharmacokinetics of different active ginseng compounds have been studied in both animals and humans.
 <xref rid="med21743-bib-0002" ref-type="ref">
  <sup>2</sup>
 </xref> The bioavailability of ginsenosides is low after oral administration, but the pharmacokinetic behavior differs among various ginsenosides.
 <xref rid="med21743-bib-0035" ref-type="ref">
  <sup>35</sup>
 </xref>, 
 <xref rid="med21743-bib-0611" ref-type="ref">
  <sup>611</sup>
 </xref> The highly glycosylated ginsenosides Rb1, Rb2, Rc, Rd., Re, Rg1, and Rg2 have poor stability in the gastrointestinal tract, and they are easily converted into monoglycosides and aglycone ginsenosides (e.g., CK, Rh2, Rh1, and F1) by gastric acid and/or the intestinal flora.
 <xref rid="med21743-bib-0035" ref-type="ref">
  <sup>35</sup>
 </xref>, 
 <xref rid="med21743-bib-0611" ref-type="ref">
  <sup>611</sup>
 </xref>, 
 <xref rid="med21743-bib-0612" ref-type="ref">
  <sup>612</sup>
 </xref>, 
 <xref rid="med21743-bib-0613" ref-type="ref">
  <sup>613</sup>
 </xref>, 
 <xref rid="med21743-bib-0614" ref-type="ref">
  <sup>614</sup>
 </xref>, 
 <xref rid="med21743-bib-0615" ref-type="ref">
  <sup>615</sup>
 </xref>, 
 <xref rid="med21743-bib-0616" ref-type="ref">
  <sup>616</sup>
 </xref>
</p>
